官方服务：
资源简介：
List of exclusionary treatments and their washout period
排除性治疗措施及其洗脱期清单
应用场景：
相关数据集
Sensitivity Analyses of Clinical Trial Designs: Selecting Scenarios and Summarizing Operating Characteristics
The use of simulation-based sensitivity analyses is fundamental for evaluating and comparing candidate designs of future clinical trials. In this context, sensitivity analyses are especially useful to
DataCite Commons2024-06-09 更新120
Treatment Selection at Interim Analysis Based on a Correlated Early Endpoint in Adaptive Two-Stage Trials with a Primary Endpoint Based on Count Data
Adaptive two-stage design with treatment selection, also called seamless Phase II/III design, has been recognized to save sample size and time to enhance the development of effective treatments. These
Taylor & Francis Group2025-07-29 更新40
Randomized non-inferiority trial involving 45-year-old women attending breast cancer screening
Breast cancer screening is effective in reducing mortality from the disease. However, the sensitivity of mammography is not optimal, which limits the effectiveness of screening, particularly in younge
Zenodo2025-03-17 更新30
Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncology
Traditional phase I dose finding cancer clinical trial designs aim to determine the maximum tolerated dose (MTD) of the investigational cytotoxic agent based on a single toxicity outcome, assuming a m
DataCite Commons2026-04-20 更新100
Design and progress status of the 11 PrEP trials appraised.
Legend: Registration code: as per the National Institute of Health trials registry. Pill(s) tested: FTC = emtricitabine; TDF = tenofovir.
NIAID Data Ecosystem40
